CN Patent

CN115197196B — Tyk2抑制剂及其用途

Assigned to Yangtze River Pharmaceutical Group Co Ltd · Expires 2024-06-18 · 2y expired

What this patent protects

本发明提供了一类式I所示的具有TYK2抑制作用的新化合物及其在制备药物中的用途。

USPTO Abstract

本发明提供了一类式I所示的具有TYK2抑制作用的新化合物及其在制备药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN115197196B
Jurisdiction
CN
Classification
—
Expires
2024-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Yangtze River Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.